CVS Health Corp vs Zimmer Biomet Holdings Inc — how do they compare? CVS Health Corp trades at $93.62 (market cap $119.58B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: CVS Health Corp is far larger — about 6.4× Zimmer Biomet Holdings Inc's market cap, and CVS Health Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| CVS | ZBH | |
|---|---|---|
Market Cap | $119.58B | $18.55B |
Sector | Health | Health |
52-Week High | $110.60 | $107.71 |
52-Week Low | $65.51 | $79.58 |
Enterprise Value | $181.93B | $25.61B |
Dividend Yield | 2.84% | 0.99% |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →